NCT03715036View on ClinicalTrials.gov

Point of Care Ultrasound Screening for Abnormal Fetal Growth During Routine Antenatal Visits

NACompletedINTERVENTIONAL
Enrollment

177

Participants

Timeline

Start Date

April 29, 2019

Primary Completion Date

March 30, 2020

Study Completion Date

March 30, 2020

Conditions
Prenatal Disorder
Interventions
DIAGNOSTIC_TEST

Point-of-care US

The intervention includes reassuring the AC and DVP

Trial Locations (1)

77555

University of Texas Medical Branch, Galveston

All Listed Sponsors
lead

The University of Texas Medical Branch, Galveston

OTHER

NCT03715036 - Point of Care Ultrasound Screening for Abnormal Fetal Growth During Routine Antenatal Visits | Biotech Hunter | Biotech Hunter